COST-EFFECTIVENESS OF MONOCLONAL-ANTIBODY 17-1A (MAB) ADJUVANT THERAPY OF RESECTED COLON-CANCER (CC) OF STAGE DUKES C IN GERMANY - A SUBGROUP ANALYSIS

Authors
BRECHT JG VOLMER T SCHADLICH PK LUTZELBERGER U
Citation
Jg. Brecht et al., COST-EFFECTIVENESS OF MONOCLONAL-ANTIBODY 17-1A (MAB) ADJUVANT THERAPY OF RESECTED COLON-CANCER (CC) OF STAGE DUKES C IN GERMANY - A SUBGROUP ANALYSIS, Annals of oncology, 9, 1998, pp. 179-179
Citations number
NO
Categorie Soggetti
Oncology
Journal title
Annals of oncology → ACNP
ISSN journal
09237534
Volume
9
Year of publication
1998
Supplement
4
Pages
179 - 179
Database
ISI
SICI code
0923-7534(1998)9:<179:COM1(A>2.0.ZU;2-P